Immunization of pigs against influenza virus infection by DNA vaccine priming followed by killed-virus vaccine boosting (Q45737947)

15 December 2017

title

Immunization of pigs against influenza virus infection by DNA vaccine priming followed by killed-virus vaccine boosting (English)

1 reference

15 December 2017

0 references

1 reference

Larsen DL

1 reference

15 December 2017

Karasin A

series ordinal

1 reference

15 December 2017

Olsen CW

series ordinal

1 reference

15 December 2017

language of work or name

English

0 references

publication date

1 April 2001

1 reference

15 December 2017

1 reference

15 December 2017

1 reference

15 December 2017

issue

20-22

1 reference

15 December 2017

page(s)

2842-2853

1 reference

Dual infections of feeder pigs with porcine reproductive and respiratory syndrome virus followed by porcine respiratory coronavirus or swine influenza virus: a clinical and virological study

15 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900014-7

7 January 2021

The prevalence of influenza viruses in swine and the antigenic and genetic relatedness of influenza viruses from man and swine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900014-7

7 January 2021

Sporadic occurrence of zoonotic swine influenza virus infections

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900014-7

7 January 2021

Isolation of swine-like influenza A(H1N1) viruses from man in Switzerland and The Netherlands

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900014-7

7 January 2021

Transmission of swine influenza virus to humans after exposure to experimentally infected pigs

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900014-7

7 January 2021

Isolation of Swine Influenza Virus from Autopsy Lung Tissue of Man

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900014-7

7 January 2021

Swine Influenza A at Fort Dix, New Jersey (January-February 1976). IV. Summary and Speculation

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900014-7

7 January 2021

Lack of significant person-to-person spread of swine influenza-like virus following fatal infection in an immunocompromised child

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900014-7

7 January 2021

Fatal swine influenza pneumonia during late pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900014-7

7 January 2021

Fatal case of swine influenza virus in an immunocompetent host

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900014-7

7 January 2021

Swine influenza virus strains recognize sialylsugar chains containing the molecular species of sialic acid predominantly present in the swine tracheal epithelium

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900014-7

7 January 2021

The nucleoprotein as a possible major factor in determining host specificity of influenza H3N2 viruses

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900014-7

7 January 2021

Fish farming and influenza pandemics

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900014-7

7 January 2021

Immunization of pigs with a particle-mediated DNA vaccine to influenza A virus protects against challenge with homologous virus

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900014-7

7 January 2021

Protection against papillomavirus with a polynucleotide vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900014-7

7 January 2021

Immune responses to nucleic acid vaccines to rabies virus

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900014-7

7 January 2021

DNA immunization confers protection against murine cytomegalovirus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900014-7

7 January 2021

DNA vaccine for hepatitis B: evidence for immunogenicity in chimpanzees and comparison with other vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900014-7

7 January 2021

DNA immunization against experimental genital herpes simplex virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900014-7

7 January 2021

Immunization with DNA vaccines encoding glycoprotein D or glycoprotein B, alone or in combination, induces protective immunity in animal models of herpes simplex virus-2 disease

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900014-7

7 January 2021

DNA-mediated immunization to hepatitis B surface antigen: longevity of primary response and effect of boost.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900014-7

7 January 2021

DNA vaccines -- a modern gimmick or a boon to vaccinology?

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900014-7

7 January 2021

DNA vaccines: protective immunizations by parenteral, mucosal, and gene-gun inoculations

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900014-7

7 January 2021

Protective immunity by intramuscular injection of low doses of influenza virus DNA vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900014-7

7 January 2021

Immunogenicity and efficacy of baculovirus-expressed and DNA-based equine influenza virus hemagglutinin vaccines in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900014-7

7 January 2021

Characterization of humoral immune responses induced by an influenza hemagglutinin DNA vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900014-7

7 January 2021

Long-Term Anti-Nucleoprotein Cellular and Humoral Immunity Is Induced by Intramuscular Injection of Plasmid DNA Containing NP Gene

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900014-7

7 January 2021

Heterologous and homologous protection against influenza A by DNA vaccination: optimization of DNA vectors.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900014-7

7 January 2021

Further protection against antigenic drift of influenza virus in a ferret model by DNA vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900014-7

7 January 2021

Expression of a viral protein by muscle cells in vivo induces protective cell-mediated immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900014-7

7 January 2021

Influenza virus nucleoprotein-specific immunoglobulin G subclass and cytokine responses elicited by DNA vaccination are dependent on the route of vector DNA delivery

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900014-7

7 January 2021

Preclinical efficacy of a prototype DNA vaccine: Enhanced protection against antigenic drift in influenza virus

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900014-7

7 January 2021

Protection of ferrets against influenza challenge with a DNA vaccine to the haemagglutinin

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900014-7

7 January 2021

Intradermal gene immunization: the possible role of DNA uptake in the induction of cellular immunity to viruses

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900014-7

7 January 2021

Enhanced protection against influenza virus of mice immunized as newborns with a mixture of plasmids expressing hemagglutinin and nucleoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900014-7

7 January 2021

Heterologous protection against influenza by injection of DNA encoding a viral protein

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900014-7

7 January 2021

Mucosal immunization with DNA encoding influenza hemagglutinin

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900014-7

7 January 2021

Poly(?-lactide-co-glycolide)-encapsulated plasmid DNA elicits systemic and mucosal antibody responses to encoded protein after oral administration

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900014-7

7 January 2021

Comparison of inactivated, live and recombinant DNA vaccines against influenza virus in a mouse model

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900014-7

7 January 2021

Coadministration of DNA encoding interleukin-6 and hemagglutinin confers protection from influenza virus challenge in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900014-7

7 January 2021

Gene transfer into mammalian cells by particle bombardment

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900014-7

7 January 2021

Antibody-forming cell response to virus challenge in mice immunized with DNA encoding the influenza virus hemagglutinin

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900014-7

7 January 2021

Long-term maintenance of B cell immunity to influenza virus hemagglutinin in mice following DNA-based immunization

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900014-7

7 January 2021

Antibody responses to DNA vaccination of horses using the influenza virus hemagglutinin gene

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900014-7

7 January 2021

IL-6 induces long-term protective immunity against a lethal challenge of influenza virus

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900014-7

7 January 2021

Intradermal DNA immunization by using jet-injectors in mice and monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900014-7

7 January 2021

In vivo gene transfer to skin and wound by microseeding

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900014-7

7 January 2021

DNA vaccination against influenza viruses: a review with emphasis on equine and swine influenza

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900014-7

7 January 2021

Systemic and mucosal immune responses to H1N1 influenza virus infection in pigs

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900014-7

7 January 2021

Superiority of the ear pinna over muscle tissue as site for DNA vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900014-7

7 January 2021

Interleukin-12 enhances the virus-specific interferon gamma response of pigs to an inactivated pseudorabies virus vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900014-7

7 January 2021

Quantitative detection of porcine interferon-gamma in response to mitogen, superantigen and recall viral antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900014-7

7 January 2021

Genetic characterization of H3N2 influenza viruses isolated from pigs in North America, 1977-1999: evidence for wholly human and reassortant virus genotypes

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900014-7

7 January 2021

Evolution of swine H3N2 influenza viruses in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900014-7

7 January 2021

First human trial of a DNA-based vaccine for treatment of human immunodeficiency virus type 1 infection: safety and host response

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900014-7

7 January 2021

DNA vaccination followed by macromolecular multicomponent peptide vaccination against HIV-1 induces strong antigen-specific immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900014-7

7 January 2021

Studies of the neutralizing activity and avidity of anti-human immunodeficiency virus type 1 Env antibody elicited by DNA priming and protein boosting

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900014-7

7 January 2021

Immune responses but no protection against SHIV by gene-gun delivery of HIV-1 DNA followed by recombinant subunit protein boosts

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900014-7

7 January 2021

DNA vaccination against virus infection and enhancement of antiviral immunity following consecutive immunization with DNA and viral vectors

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900014-7

7 January 2021

Boosting with recombinant vaccinia increases immunogenicity and protective efficacy of malaria DNA vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900014-7

7 January 2021

Combining DNA and protein vaccines for early life immunization against respiratory syncytial virus in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900014-7

7 January 2021

Gene gun intradermal DNA immunization followed by boosting with modified vaccinia virus Ankara: enhanced CD8+ T cell immunogenicity and protective efficacy in the influenza and malaria models

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900014-7

7 January 2021

A prime-boost immunization strategy with DNA and recombinant baculovirus-expressed protein enhances protective immunogenicity of glycoprotein D of equine herpesvirus 1 in naïve and infection-primed mice

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900014-7

7 January 2021

Neutralizing antibody-independent containment of immunodeficiency virus challenges by DNA priming and recombinant pox virus booster immunizations

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900014-7

7 January 2021

A novel vaccine regimen utilizing DNA, vaccinia virus and protein immunizations for HIV-1 envelope presentation

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900014-7

7 January 2021

Pre-clinical development of a multi-CTL epitope-based DNA prime MVA boost vaccine for AIDS

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900014-7

7 January 2021

Induction of AIDS virus-specific CTL activity in fresh, unstimulated peripheral blood lymphocytes from rhesus macaques vaccinated with a DNA prime/modified vaccinia virus Ankara boost regimen

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900014-7

7 January 2021

Cross-protection in mice infected with influenza A virus by the respiratory route is correlated with local IgA antibody rather than serum antibody or cytotoxic T cell reactivity

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900014-7

7 January 2021

Functional role of respiratory tract haemagglutinin-specific IgA antibodies in protection against influenza

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900014-7

7 January 2021

Dose response of A/Alaska/6/77 (H3N2) cold-adapted reassortant vaccine virus in adult volunteers: role of local antibody in resistance to infection with vaccine virus

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900014-7

7 January 2021

Serum and nasal wash antibodies associated with resistance to experimental challenge with influenza A wild-type virus

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900014-7

7 January 2021

Cytotoxic T-cell immunity to influenza.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900014-7

7 January 2021

Heterotypic protection against influenza by immunostimulating complexes is associated with the induction of cross-reactive cytotoxic T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900014-7

7 January 2021

Contribution of virus-specific CD8+ cytotoxic T cells to virus clearance or pathologic manifestations of influenza virus infection in a T cell receptor transgenic mouse model

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900014-7

7 January 2021

Determinants of immunity to influenza infection in man

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900014-7

7 January 2021

Protection with split and whole virus vaccines against influenza

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900014-7

7 January 2021

Effect of intratracheal challenge of fattening pigs previously immunised with an inactivated influenza H1N1 vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900014-7

7 January 2021

Proved viraemia in asian influenza (Hong Kong variant) during incubation period

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900014-7

7 January 2021

HUMAN INFLUENZA INFECTION WITH PROVED VIREMIA. REPORT OF A CASE

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900014-7

7 January 2021

Pathogenicity of a swine influenza H1N1 virus antigenically distinguishable from classical and European strains

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900014-7

7 January 2021

Virologic and serologic surveillance for human, swine and avian influenza virus infections among pigs in the north-central United States.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900014-7

7 January 2021

10.1016/S0264-410X(01)00014-7

Identifiers

DOI

1 reference

15 December 2017

1 reference